Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
Astrocytes Promote Oligodendrogenesis after White Matter Damage via Brain-Derived Neurotrophic Factor.
7 Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis.
[Special cases of multiple sclerosis].
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
[Non-medicinal treatments of spasticity in multiple sclerosis].
Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes.
The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity.
Moral Distress: Recognition, Diagnosis, and Treatment.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »